|
|
 |
| |
|
Home > Fortune 500 Companies > Triad Hospitals
Triad Hospitals
Triad Hospitals is a publicly traded company having a good stock performance result. Triad Hospitals is a fortune 500 stock listed company trading under TRI.
Triad Hospitals, Inc., through its affiliates, owns and manages hospitals and ambulatory surgery centers in small cities and selected larger urban markets. The Company currently operates 51 hospitals and 10 ambulatory surgery centers in 16 states with approximately 9,300 licensed beds. Additionally, through its QHR subsidiary, the Company provides consulting, education, intensive resources and management services to hospitals and health systems throughout the United States.
The company announced consolidated financial results for the 3 months and year ended December 31, 2005. For the 3 months, the Company reported revenues of 1.3 billion dollars; earnings before interest, taxes, depreciation, amortization, and other items of 176.7 million dollars; net income of 54.6 million dollars; income from continuing operations of 59.0 million dollars; diluted earnings per share of 0.63 dollars; and diluted EPS from continuing operations of 0.68 dollars.
The Company reported a provision for doubtful accounts of 122.8 million dollars, or 9.7 percent of revenue for 3 months. Excluding the self-pay discounts of 45.2 million dollars, the company estimates that the provision for doubtful accounts would have been 12.8 percent of revenue. The three months, cash flow from operating activities was 68.4 million dollars, or 118.1 million dollars excluding cash interest payments of 49.3 million dollars and cash tax payments of 0.4 million dollars.
For the year, the company reported revenues of 4.7 billion dollars; adjusted EBITDA of 712.4 million dollars; net income of 226.0 million; income from continuing operations of 229.4 million dollars; diluted EPS of 2.70 dollars; diluted EPS from continuing operations of 2.74 dollars; and diluted EPS from continuing operations excluding refinancing transaction costs of 2.80 dollars.
The company expects to achieve diluted EPS from continuing operations of approximately 2.81-2.93 dollars. Effective January 1, 2006, the Company began recording stock compensation expense, in accordance with Statement of Financial Accounting Standards 123; excluding stock compensation expense, which is expected to be approximately 20 million dollars after-tax, or 0.23 dollars per diluted share, Triad expects to achieve diluted EPS from continuing operations of approximately 3.04-3.16 dollars.
The Company provides consulting, education, intensive resources and management services to hospitals and health systems throughout the U.S.
Back to Fortune 500 Companies
|
|
|
|
|
|
|